Variable | Viral load | Unadjusted OR | P-value | Adjusted OR | P-value | |
---|---|---|---|---|---|---|
Unsuppressed | Suppressed | (95% CI) | (95% CI) | |||
Age Group | ||||||
14–18 | 16 | 247 | 1 | 1 | ||
19–29 | 87 | 1925 | 0.70 (0.40–1.21) | 0.199 | 3.17 (1.17–5.17) | 0.002** |
30–40 | 101 | 3955 | 0.40 (0.23–0.94) | 0.001* | 1.99 (0.26–3.72) | 0.025 |
> 40 | 47 | 1386 | 0.52 (0.29–0.94) | 0.030 | 3.12 (0.93–5.33) | 0.005 |
ART Regimen | ||||||
First Line | 234 | 7234 | 1 | 1 | ||
Second Line | 12 | 159 | 2.33 (1.28–4.26) | 0.006* | 0.014 (95% CI 0.003–0.071 | 0.001*** |
Third Line | 5 | 120 | 1.29 (0.52–3.18) | 0.583 | 2.43 (0.15–4.70) | 0.037 |
Timing for testing | ||||||
1st test at ANC (only once during the first ANC) | 74 | 2499 | 0.75 (0.57–1.00) | 0.052 | 1.75 (0.20–3.30) | 0.027 |
2nd VL at 6 Month | 32 | 1320 | 0.62 (0.42–0.91) | 0.015* | 1.08 (− 0.65–2.82) | 0.222 |
Until 34th–36th weeks of gestation | 145 | 2694 | 1 | 1 | ||
Adherence | ||||||
Good | 5 | 7499 | 1 | 1 | ||
Poor | 246 | 14 | 10.18 (9.15–11.21) | 0.000*** | 12.64 (10.74–14.54) | 0.001*** |